Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0338671 (
Steroids
)
9,479
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Steroid hormones induce changes in gene expression by binding to intracellular receptors that then translocate to the nucleus.
Steroids
have also been shown to rapidly modify cell function by binding to surface membrane receptors. We identified a candidate steroid membrane receptor, the progestin and adipoQ receptor (PAQR) 10, a member of the PAQR family, in a screen for genes differentially expressed in mouse pancreatic beta-cells.
PAQR10
gene expression was tissue restricted compared with other PAQRs. In the mouse embryonic pancreas,
PAQR10
expression mirrored development of the endocrine lineage, with
PAQR10
protein expression confined to endocrine islet-duct structures in the late embryo and neonate. In the adult mouse pancreas,
PAQR10
was expressed exclusively in islet cells except for its reappearance in ducts of maternal islets during pregnancy.
PAQR10
has a predicted molecular mass of 29 kDa, comprises seven transmembrane domains, and, like other PAQRs, is predicted to have an intracellular N-terminus and an extracellular C-terminus. In silico analysis indicated that three members of the PAQR family, PAQRs 9, 10, and 11, have a candidate mitochondrial localization signal (MLS) at the N-terminus. We showed that
PAQR10
has a functional N-terminal MLS and that the native protein localizes to mitochondria.
PAQR10
is structurally related to some bacterial hemolysins, pore-forming virulence factors that target mitochondria and regulate apoptosis. We propose that
PAQR10
may act at the level of the mitochondrion to regulate pancreatic endocrine cell development/survival.
...
PMID:Pancreatic expression and mitochondrial localization of the progestin-adipoQ receptor PAQR10. 1876 39